News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ViroXis Corporation Achieves Key Clinical Milestones


2/20/2014 9:09:13 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN ANTONIO--(BUSINESS WIRE)--ViroXis Corporation today announced that the final patient has completed treatment in its Phase 2 clinical study of the Company’s East Indian Sandalwood Oil (EISO) based therapy for HPV/common skin warts. Efficacy and safety results will be known once the data is analyzed in April following a three-month follow-up period.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES